Harwood_2011_CNS.Neurol.Disord.Drug.Targets_10_333

Reference

Title : Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity - Harwood_2011_CNS.Neurol.Disord.Drug.Targets_10_333
Author(s) : Harwood AJ
Ref : CNS Neurol Disord Drug Targets , 10 :333 , 2011
Abstract :

Inhibition of prolyl oligopeptidase (PO) elevates inositol phosphate (IP) signalling and reduces cell sensitivity to lithium (Li+). This review discusses recent evidence that shows PO acts via the multiple inositol polyphosphate phosphatase (MIPP) to regulate gene expression. As a consequence, PO inhibition causes both a transient, rapid increase in I(1,4,5)P(3) and a long-term elevation of IP signalling. This pathway is evolutionary conserved, being present in both the social amoeba Dictyostelium and human cell systems, and has potential implications for mental health.

PubMedSearch : Harwood_2011_CNS.Neurol.Disord.Drug.Targets_10_333
PubMedID: 21222625

Related information

Citations formats

Harwood AJ (2011)
Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity
CNS Neurol Disord Drug Targets 10 :333

Harwood AJ (2011)
CNS Neurol Disord Drug Targets 10 :333